Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 01, 2005 (Vol. 25, No. 19)

Frontiers in Bioscience

  • Unparalleled in scope
  • None
Site of an online worldwide journal and virtual library, Bioscience.org is one of the oldest online journals, dating back to 1996. The publication appears to have a once yearly frequency. Access to issues since 2000 are for subscribers only, but earlier articles are freely available. There is much more to the site however, than just the journal. Other highlights include a Knowledge Center (full of databases of biochemistry interest), the Encyclopedia of Bioscience (vast collection of mostly health-related information), a Library (much miscellaneous information, including calendars, calculators, converters, dictionaries, etc.), Online Classifieds, and a catch-all category of company information, product information, and resources called Biomail. There is more information at this site than I can list in one paragraph. That should tell you a lot about what Bioscience.org has to offer. It is one of the most comprehensive sites of its type I've ever seen.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »